Pheniprazine

This classification denotes a monoamine oxidase inhibitor with the molecular formula C9H14N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 37VKD7067M, chemically known as hydrazine, (.alpha.-methylphenethyl)-, monohydrochloride but generally known as pheniprazine, which bears US NIH Compound Identifier 5929. European Medicines Agency schedules Pheniprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09767MIG. The term PHENIPRAZINE is an International Non-Proprietary Name. PHENIPRAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pheniprazine under HS 29280090 and SITC 51486. As of Q4 2014, PHENIPRAZINE remains the US FDA Preferred Term for this commodity. Pheniprazine bears US NLM identifiers UMLS ID C0031407 and NCI Concept Code C80967. SMILES: N(N)C(CC1CCCCC1)C.